SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1314151617181920Next Page
2026-08-11CYBN6-KHelus Pharma (Cybin) to Present at Canaccord Genuity 46th Annual Growth Conference
Cybin Inc. (operating as Helus Pharma) announced that its Chief Executive Officer, Michael Halstead, will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference in Boston. The presentation is scheduled for Wednesday, August 12, 2026, at 12:00 p.m. EDT and will be available via a live webc...
BiotechnologyOthers
2026-08-11CMND6-KClearmind Medicine Announces Positive Permeation Results for Intranasal MEAI FormulationMEDIUM
Clearmind Medicine Inc. (Nasdaq: CMND) announced positive results from a permeation study within its ongoing intranasal MEAI (5-Methoxy-2-aminoindane) development program. The study, conducted using Franz diffusion cells, aimed to evaluate whether the company's proprietary mucoadhesive formulation influenced drug deliv...
Nano CapBiotechnologyTrial Result Positive
Previous Page1314151617181920Next Page